Crossmark

Targeting <scp>YAP</scp> to overcome acquired resistance to <scp>ALK</scp> inhibitors in <i> <scp>ALK</scp> </i> ‐rearranged lung cancer

Crossref DOI link: https://doi.org/10.15252/emmm.201910581

Published Online: 2019-10-21

Published Print: 2019-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Yun, Mi Ran https://orcid.org/0000-0002-2398-3287
Choi, Hun Mi

Lee, You Won

Joo, Hyeong Seok

Park, Chae Won

Choi, Jae Woo

Kim, Dong Hwi

Kang, Han Na

Pyo, Kyoung‐Ho

Shin, Eun Joo

Shim, Hyo Sup

Soo, Ross A

Yang, James Chih‐Hsin

Lee, Sung Sook

Chang, Hyun

Kim, Min Hwan

Hong, Min Hee

Kim, Hye Ryun

Cho, Byoung Chul https://orcid.org/0000-0002-5562-270X
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2014R1A1A1006865)

National Research Foundation of Korea (2016R1A2B3016282)
License Information

Version of Record valid from 2019-10-21
More Information

Publication History

Received: 2019-03-11

Accepted: 2019-09-24

Published: 2019-10-21